Navigation Links
IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
Date:11/1/2007

IRVINE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced the presentation of updated survival data from the Phase 3 mifamurtide (L-MTP-PE) clinical trial (INT-0133). The trial was part of a National Cancer Institute (NCI) funded cooperative group study conducted by the Children's Oncology Group (COG) and the data is based on long-term follow up of patients originally treated in the Phase 3 trial. The results demonstrated that the addition of L-MTP-PE, formerly known as Junovan, to chemotherapy during treatment for osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults, achieved statistically superior Overall Survival (OS) rates.

"The statistically significant survival findings of L-MTP-PE in combination with chemotherapy in this study are very encouraging, particularly when compared to the outcome of these patients for the last 20 years," said Dr. Meyers, vice chair, department of pediatrics at Memorial Sloan Kettering Cancer Center and principal investigator of the Phase 3 trial. "These results are especially encouraging for the critically ill children and young adults with osteosarcoma who need an innovative treatment option for this devastating disease."

The data were presented during an oral presentation at the Connective Tissue Oncology Society (CTOS) annual meeting today in Seattle.

"We are very pleased to see that the overall survival benefit shown in the primary analysis of the Phase 3 clinical trial data was further strengthened by the statistically superior findings in long-term patient follow-up," said Timothy P. Walbert, president and chief executive officer, IDM Pharma. "As we announced on August 27, 2007 w
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Intarcia Therapeutics, Inc. today ... into the newly created role of Chief Operating ... executive with world-class experience – most recently at ... at industry leaders such as Pfizer and Bristol ... of therapeutic areas, including: cardiovascular, metabolic, oncology, neuroscience, ...
(Date:5/4/2015)... , May 4, 2015 CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to treat ... worldwide, will report Q1 2015 financial results after ... CytoSorbents, management will host a ... recount both operational and financial progress during Q1 ...
(Date:5/4/2015)... May 4, 2015  Caris Life Sciences®, a ... of precision medicine, today announced the designation of ... in the Caris Centers of Excellence for Precision ... Maryland and the ... a leader in oncology research and treatment, with ...
Breaking Medicine Technology:Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 2Caris Life Sciences Designates MedStar Health a Caris Center of Excellence 3
... , , Agency Experts ... , SILVER SPRING, Md., Dec. 23 As part of its ... FDA has scheduled a series of workshops about orphan drug designation ... FDA can grant a special status, known as orphan designation, for ...
... , BOSTON, Dec. 23 Solos Endoscopy, Inc. (Pink ... has outlined its 2010 marketing strategy as developed by ... marketing campaign will focus primarily on the MammoView(TM) line. ... medical publications, development of a media-advertising program, production of ...
Cached Medicine Technology:FDA: Orphan Drug Workshops Scheduled For Feb. 25-26 and Aug. 3-4, 2010 2Solos Endoscopy, Inc. Outlines Marketing Strategy for 2010 Campaign 2
(Date:5/4/2015)... Ticket Down is a reputable source for authentic ... While the World Cup is the most known soccer ... the International Champions Cup is one of the biggest tournaments ... record for soccer in the United States set when Manchester ... University of Michigan. This year, the defending champion Manchester United ...
(Date:5/4/2015)... May 04, 2015 Los Angeles ... offering a more comfortable and attractive alternative for patients ... choice for those who have lost teeth. Unfortunately, they ... insecure or slip at the worst possible moment and ... talks. They can also painfully pinch or rub gums, ...
(Date:5/4/2015)... New findings released today from a poll conducted ... people diagnosed with a brain tumor needed more information ... at the time of diagnosis, and had only a ... course of treatment. The release of these findings corresponds ... volunteer network, the ABTA CommYOUnity™, dedicated to serving the ...
(Date:5/4/2015)... May 04, 2015 San Diego ... ceremony at their brand new, 13,700 square foot facility ... new building will not only provide fertility treatment and ... also offer community and educational events to a number ... is located next door to their current Carmel Valley/Del ...
(Date:5/4/2015)... MT (PRWEB) May 04, 2015 New ... with Care to Care, LLC to manage outpatient advanced ... help New West Medicare ensure its members are provided ... unnecessary radiation. , Working closely with New West Medicare’s ... promoting the safe use of advanced imaging and provide ...
Breaking Medicine News(10 mins):Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 2Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 3Health News:Cheap 2015 International Champions Cup (ICC) Tickets: Ticket Down Slashes Ticket Prices on International Champions Cup (ICC) Presale Tickets 4Health News:Los Angeles Dental Implants Doctor, Kevin Sands DDS, Now Offers a More Comfortable and Aesthetically-Pleasing Solution to Denture-Wearers 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2
... among college students has long been viewed as ... spend millions of dollars annually on public service ... hazardous drinking habits. These organizations primarily use "loss-framed", ... binge drinking. Now, University of Missouri researchers have ...
... HealthDay Reporter , WEDNESDAY, June 1 (HealthDay News) -- ... for decades by millions of people -- may eventually have ... studies. One study suggests that women who are already ... diagnosed with breast cancer at an earlier stage of the ...
... a hospital is readmitted within a month. Seeking to ... door hospital readmissions, the Affordable Care Act proposes a ... and reduce costs for the growing population of chronically ... a central theme in these provisions, there is little ...
... The Reed Elsevier Environmental Challenge aims to encourage innovative ... supply for communities where it is presently at risk. ... announced today, is Tagore-SenGupta Foundation. Their project involves installation ... and schools in Cambodia where arsenic groundwater contamination is ...
... recently published paper highlights that while the risk of post-traumatic ... than those without migraine irrespective of sex, the risk is ... now available in Headache: The Journal of Head and ... American Headache Society. In this paper, lead author ...
... other technologies harnessing health data to improve people,s and ... Initiative Forum, hosted by the Institute of Medicine and ... June 9. IT developers, health policy experts, company ... by the Institute of Medicine and U.S. Department of ...
Cached Medicine News:Health News:College students respond better to positive anti-binge drinking messages 2Health News:Widely Used Heart Drugs Linked to Better Breast Cancer Outcomes 2Health News:Widely Used Heart Drugs Linked to Better Breast Cancer Outcomes 3Health News:Reducing revolving door hospital re-admissions 2Health News:Reed Elsevier Environmental Challenge winners announced 2Health News:Sex matters -- more men with migraine suffer from PTSD than women 2Health News:Sex matters -- more men with migraine suffer from PTSD than women 3Health News:Health data forum features dynamic apps, experts on June 9 2
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Ammonia in plasma...
For the quantitative in vitro determination of Sodium in serum and plasma....
Enzymatic assay for the quantitative in vitro determination of glycated protein (fructosamine) in human serum or plasma....
Medicine Products: